According to a randomized controlled trial, dronedarone is envisioned as a safer alternative to amiodarone in patients with atrial fibrillation. Medscape Medical News
At a mean of 4.9 years, risk for atherosclerotic events was reduced by 17% among patients taking the combo drug vs placebo. Risk for vascular events was also significantly reduced, by 15.3%. Heartwire
Authors of the study say their study does not rule out a role for ankle/brachial index screening in the clinic or for other CVD drugs to reduce risk in asymptomatic subjects. But for aspirin and for populationwide screening, the study raises some questions. Heartwire
Inflammatory bowl disease (IBD) and ulcerative colitis can be risk factors for thromboembolism, causing significant morbidity and mortality. Southern Medical Journal
